BeOne Medicines (ONC) Assets Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.82% |
| Dec 31, 2025 | 14.32% |
| Sep 30, 2025 | 4.30% |
| Jun 30, 2025 | -5.14% |
| Mar 31, 2025 | -10.03% |
| Dec 31, 2024 | -11.48% |
| Sep 30, 2024 | 3.32% |
| Jun 30, 2024 | 1.12% |
| Mar 31, 2024 | -0.89% |
| Dec 31, 2023 | 1.20% |
| Sep 30, 2023 | -0.25% |
| Jun 30, 2023 | 13.64% |
| Mar 31, 2023 | 13.56% |
| Dec 31, 2022 | 50.36% |
| Sep 30, 2022 | 52.92% |
| Jun 30, 2022 | 50.83% |
| Mar 31, 2022 | 54.57% |
| Dec 31, 2021 | 55.97% |
| Sep 30, 2021 | 29.96% |
| Jun 30, 2021 | 49.48% |
| Mar 31, 2021 | 50.46% |
| Dec 31, 2020 | 74.92% |
| Sep 30, 2020 | 74.42% |
| Jun 30, 2020 | 101.94% |
| Mar 31, 2020 | 121.02% |
| Dec 31, 2019 | 58.38% |
| Sep 30, 2019 | 99.92% |
| Jun 30, 2019 | 104.56% |
| Mar 31, 2019 | 101.57% |
| Dec 31, 2018 | 168.08% |